Post by Théodore Leondaridis

🎯2026: Accelerating Our Oncology Ambition as One Pierre Fabre Oncology 2 weeks ago, I had the chance to be with our General Managers, Regional Managers and my Pharma Leadership team from across the world 🌎 https://lnkd.in/ee4Q7gdw - Congratulations Fernando Junoy and Marie-Andrée Gamache for the engagement throughout the day 🔋 It was not “just another meeting”. It was an energizing moment to kick off our 2026 annual strategy in Oncology – with purpose-driven ambitions and zero comfort zone. Congratulations for the excellent 2025 achievements! 💪We were honest, we were bold, and we were aligned on one thing: 2026 is not business as usual. It’s acceleration mode. Our annual strategy for 2026 is clear 🎯 but it will only be powerful if it is locally owned. Every market matters. Local market importance is huge: this is where strategy becomes real impact for oncologists and patients 🧩 FOR SURE, I'll visit China ( @Tian Wee Ng), the USA ( @adriana herrera) and Germany ( @Nina Menghini) and FOR SURE many more. 🛣️For me, the roadmap is simple and demanding: 1️⃣Hypercaring for new launches 2️⃣ Where we play, we lead 3️⃣ Bring new medicines to patients with a powerful R&D & partnership engine. 👉To make this real, we need the right culture: Courage and Boldness, Ability to turn trategy into impact, Energized and Mobilized teams across all our markets – so that we can really deliver for more patients. Let's #RevolutionizeCancerCareTogether 🚀 Stéphan Bergonzi Diana Bou Merhy Regis COULON Kristel De Bisschop  Dr. Hande Demirdere  Giuseppe Di Majo  Beata Dobicka-Miś  Roman Dušil  Vincent Guiraud-Chaumeil Axel Kaass  Tian Wee Ng Sercan Özen Yıldırım Jairo PARDEY Gilda Parreira  Alan PEYON  adriana herrera Linda TIBBITS  Evgenia Kostova Cindy YEH  Nicolas Zombré  Tran Tuan Hung Laurent-Emmanuel Saffre Jaclyn C. Sonia Hammami Maya Daher Abou Jaoudé